Thursday, October 13, 2022

Outcomes in Patients With Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors

alexandrossfakianakis shared this article with you from Inoreader

ooi220045t1_1664995497.34322.png?Expires

This cohort study assesses survival outcomes and response rates among patients with recurrent or metastatic mucosal head and neck squamous cell carcinoma treated with checkpoint inhibitors with or without chemotherapy.
View on Web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...